SAME TT2R2 score

S
A
Me
T
T2
R2

Sex

Male (0)

Female (+1)

Age

Age < 60 years (+1)

Age 60 ≥ years (0)

Medical history (Two of the following: hypertension, diabetes mellitus, coronary artery disease, peripheral artery disease, congestive heart failure, prior stroke, pulmonary disease, hepatic or renal disease)

Yes (+1)

No (0)

Interacting treatment e.g. amiodarone for rhythm control

Yes (+1)

No (0)

Tobacco use (within 2 years)

Yes (+2)

No (0)

Race

Non-caucasian (+2)

Caucasian (0)

Result

Total score: 0

Reference

Rami Riziq-Yousef Abumuaileq, Emad Abu-Assi, Sergio Raposeiras-Roubin, Andrea López-López, Alfredo Redondo-Diéguez, Diego Álvarez-Iglesias, Moisés Rodríguez-Mañero, Carlos Peña-Gil, Jose Ramón González-Juanatey, Evaluation of SAMe-TT2R2 risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists, EP Europace, Volume 17, Issue 5, May 2015, Pages 711–717, https://doi.org/10.1093/europace/euu353

SAME TT2R2 score

S A Me T T2 R2

S
A
Me
T
T2
R2